Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Leong

Showing results (161-170 of 186) with videos related to

Pageof 19
Sort By:
Cancer|March 15, 1994
High-dose doxorubicin, etoposide, and cyclophosphamide with stem cell reinfusion in patients with metastatic or high-risk primary breast cancer. City of Hope Bone Marrow Oncology TeamG Somlo, J H Doroshow, S J Forman, et al.
Cancer|January 1, 1994
High-dose cisplatin, etoposide, and cyclophosphamide with autologous stem cell reinfusion in patients with responsive metastatic or high-risk primary breast cancerG Somlo, J H Doroshow, S J Forman, et al.
The Annals of Pharmacotherapy|November 28, 2002
Quality-of-life assessment in an outpatient parenteral antibiotic programAlan F Goodfellow, Amy O Wai, Luciana Frighetto, et al.
Urogynecology (Philadelphia, Pa.)|June 4, 2026
Follow-up After Urogynecologic Surgery: A Systematic Review and Meta-AnalysisBrittany L Roberts, Karissa A Leong, Caitlin E Carlton, et al.
BMC Health Services Research|June 9, 2005
Willingness to pay to assess patient preferences for therapy in a Canadian settingCarlo A Marra, Luciana Frighetto, Alan F Goodfellow, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1995
Effect of low-dose prophylactic dopamine on high-dose cisplatin-induced electrolyte wasting, ototoxicity, and epidermal growth factor excretion: a randomized, placebo-controlled, double-blind trialG Somlo, J H Doroshow, A Lev-Ran, et al.
Diabetes|April 3, 2019
T-Cell-Specific PTPN2 Deficiency in NOD Mice Accelerates the Development of Type 1 Diabetes and Autoimmune ComorbiditiesFlorian Wiede, Thomas C Brodnicki, Pei Kee Goh, et al.
Cancer Research|May 1, 1992
Pharmacokinetics and toxicity of continuous infusion (6S)-folinic acid and bolus 5-fluorouracil in patients with advanced cancerE M Newman, S A Akman, J S Harrison, et al.
Optics Express|July 21, 2015
Sub-Nyquist field trial using time frequency packed DP-QPSK super-channel within fixed ITU-T gridL Potì, G Meloni, G Berrettini, et al.
Cancer Chemotherapy and Pharmacology|July 27, 2000
Pharmacokinetics and toxicity of high-dose intravenous methotrexate in the treatment of leptomeningeal carcinomatosisM L Tetef, K A Margolin, J H Doroshow, et al.
Pageof 19

Showing results (161-170 of 186) with videos related to

Sort By:
Pageof 19
Cancer|March 15, 1994
High-dose doxorubicin, etoposide, and cyclophosphamide with stem cell reinfusion in patients with metastatic or high-risk primary breast cancer. City of Hope Bone Marrow Oncology TeamG Somlo, J H Doroshow, S J Forman, et al.
Cancer|January 1, 1994
High-dose cisplatin, etoposide, and cyclophosphamide with autologous stem cell reinfusion in patients with responsive metastatic or high-risk primary breast cancerG Somlo, J H Doroshow, S J Forman, et al.
The Annals of Pharmacotherapy|November 28, 2002
Quality-of-life assessment in an outpatient parenteral antibiotic programAlan F Goodfellow, Amy O Wai, Luciana Frighetto, et al.
Urogynecology (Philadelphia, Pa.)|June 4, 2026
Follow-up After Urogynecologic Surgery: A Systematic Review and Meta-AnalysisBrittany L Roberts, Karissa A Leong, Caitlin E Carlton, et al.
BMC Health Services Research|June 9, 2005
Willingness to pay to assess patient preferences for therapy in a Canadian settingCarlo A Marra, Luciana Frighetto, Alan F Goodfellow, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1995
Effect of low-dose prophylactic dopamine on high-dose cisplatin-induced electrolyte wasting, ototoxicity, and epidermal growth factor excretion: a randomized, placebo-controlled, double-blind trialG Somlo, J H Doroshow, A Lev-Ran, et al.
Diabetes|April 3, 2019
T-Cell-Specific PTPN2 Deficiency in NOD Mice Accelerates the Development of Type 1 Diabetes and Autoimmune ComorbiditiesFlorian Wiede, Thomas C Brodnicki, Pei Kee Goh, et al.
Cancer Research|May 1, 1992
Pharmacokinetics and toxicity of continuous infusion (6S)-folinic acid and bolus 5-fluorouracil in patients with advanced cancerE M Newman, S A Akman, J S Harrison, et al.
Optics Express|July 21, 2015
Sub-Nyquist field trial using time frequency packed DP-QPSK super-channel within fixed ITU-T gridL Potì, G Meloni, G Berrettini, et al.
Cancer Chemotherapy and Pharmacology|July 27, 2000
Pharmacokinetics and toxicity of high-dose intravenous methotrexate in the treatment of leptomeningeal carcinomatosisM L Tetef, K A Margolin, J H Doroshow, et al.
Pageof 19